An Online Event

When: Wednesday, January 19, 2022, 18:30-19:30 (Greece)

Where: You can watch it here.
The lecture will be held in Greek.

Organized by: Institute of Public Health – The American College of Greece

Novel Clinical Applications of Human Genetics in Diagnosis & Therapy of Hereditary Cancer

Drakoulis Yannoukakos
Director of Research – Human Genetics Field,
Molecular Diagnostics Laboratory INRASTES,
National Centre for Scientific Research DEMOKRITOS, Athens

For more information, please contact: +30 210 331 4755

You can watch the videos of previous lectures here.

Speaker’s bio

Drakoulis Yannoukakos
Director of Research – Human Genetics Field,
Molecular Diagnostics Laboratory INRASTES,
National Centre for Scientific Research DEMOKRITOS, Athens

Dr. Drakoulis Yannoukakos is Director of Research in the field of Human Genetics at the Molecular Diagnostics Laboratory of the Institute of Nuclear & Radiological Sciences and Technology, Energy & Safety (INRASTES), NCSR “Demokritos”. He graduated from the Chemistry Department of Aristotle University of Thessaloniki in 1984. He then completed his Postgraduate Diploma in Enzymology at Paris XI and his Doctorate in Biochemistry at Paris XII (1987-1991). He worked as a post-doctoral associate in the Molecular Medicine Department of the Beth Israel Hospital, Harvard Medical School (1991-94) and then in the field of Molecular Pharmacology of the Medical School, New York University (1994-95). He was appointed to NCSR “Demokritos” as an Assistant Researcher in 1995, while he created the Molecular Diagnostics Laboratory in 1998, which later developed as a reference laboratory in the field of Cancer Genetics in Greece. He is visiting Professor in the following Post-graduate Programs: Clinical Biochemistry – Molecular Diagnostics, Dept. of Biology, Athens University (2007-today), Human Genetics, Medical School, University of Thessaly (2014-today), Oncology: From Oncogenesis to Therapy, Medical School, University of Crete-NHRF (2019-today) and Human Genetics, Democritus University of Thrace (2018). His research focuses on the analysis of Hereditary Cancer Predisposition Syndromes and Rare Diseases. He has published more than 140 articles in peer-reviewed journals and has been reviewer in international journals and funding institutions. He has supervised 13 PhD theses in the field of Cancer Genetics. He has received research funding from the General Secretariat for Research and Technology, the European Union, the Hellenic Association of Women with Breast Cancer “Alma Zois”, the Hellenic Cooperative Oncology Group, the Hellenic Society of Medical Oncology and Pharmaceutical Companies. He participates in major international consortia on Cancer Genetics (Consortium of Investigators of Modifiers of BRCA1 and BRCA2 – CIMBA, Breast Cancer Association Consortium – BCAC, Evidence-based Network for the Interpretation of Germline Mutant Alleles – ENIGMA, Ovarian Cancer Association Consortium – OCAC, The Triple Negative Breast Cancer Consortium- TNBCC, and The PALB2 Consortium).